Meirigeng QiRam KannanDongyun YangTijana Jovanovic-TalismanMichael B. MannXiyong LiuQiang GongRamon EritjaSachith Gallolu KankanamalageAjay GoelYuanzhong WangXiaoqiang WangMonzr M Al MalkiHalesha BasavarajappaBijender KumarAmy CookDuc NguyenDavide MaestriniMonica MarzagalliYi-Chang WangJing ZhangYiqiang ZhangZhengke LiYang WangPiroska E SzabóXianghui FuChia-Lei LinEmine Gulsen GunesChun-Wei ChenJonathan JuiPierre WalletElisabeth de VriesCharlie ZhongD D KlothPeter P LeeF D HongTimothy SynoldDan ZhaoJanet A CrumAnthony K N Chan
P108
P20
P361
Immunotherapy Study for Surgically Resected Pancreatic CancerA Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) PatientsCT Antigen TCR-redirected T Cells for Ovarian Cancer.Study of Personalized Immunotherapy in Adults With Metastatic Colorectal CancerA Study of R1507 in Participants With Recurrent or Refractory SarcomaIsavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare FungiZevalin-beam for Aggressive LymphomaPhase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast CancerEfficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Accelerated Phase or Blast Phase (Blast Crisis)Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell LymphomaEvaluation of a Video Game for Adolescents and Young Adults With CancerThe Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) StudyStudy of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell LymphomaA Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 RegimenA Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder CancerPhase 2 Study of Carfilzomib in Relapsed and Refractory Multiple MyelomaBelinostat in Relapsed or Refractory Peripheral T-Cell LymphomaEvaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate CancerAn Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) CancersScleroderma: Cyclophosphamide or Transplantation (SCOT)Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic PatientsA Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related CancersA Research Study for Patients With Metastatic Renal Cell CarcinomaContinuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer PatientsMobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma PatientsMobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma PatientsPhase II Palbociclib +Ibrutinib in Mantle Cell LymphomaExtended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma PatientsDose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has ReturnedEfficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric PatientsStudy Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic LeukemiaThe Adv Halt TrialA Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based ChemotherapyA Safety and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies (PLATFORM)A Study to Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory DLBCL and/or High-Grade B-Cell Lymphoma and/or High Grade B-Cell
P6153
Q37830401-B36969C6-8187-40E9-A4CB-005D2952CB19Q38321251-ABB1D9AA-0560-429E-A20B-D22614D46729Q39479438-EF3DE681-2168-4D8D-B49A-378AA942E69CQ41049862-7E735D75-9B06-4ADB-818D-BFA063ED8C16Q41625188-1D4B31B7-70A7-4450-B21C-63BA2FA0131FQ41625188-CF187B77-32AB-45F0-A03A-05630701A7E0Q42176179-209C4240-4653-4A43-B540-A4C242902F87Q42176179-37AB8481-6601-4ED9-9C66-6046C9CB8744Q42397588-9A8DBB06-9112-49B6-ADF5-D4078137EC1EQ42621686-B5491772-C8C3-457E-BF7F-BE4FE6A6C516Q42621686-CF8D1859-1BAC-4EDA-9A3D-406B7A4575F9Q50137447-E9FDF25C-3E8F-4705-A357-F3A434D20F40Q50723416-17ABE670-5E58-453D-9576-719ACE290449Q56056759-989A59A5-C8A7-48E6-AD88-E827DC4E348AQ56056759-C2A2A50C-1D90-4CB1-954A-9E73B8526B0DQ56056759-E9D87776-8819-49B3-857C-682155783EF2Q56811423-A4356ADF-B5C8-4591-9F8A-0205E139F9DAQ56995356-53238C94-DFE4-442F-B04C-BD5EE85AC4CAQ56999978-165836A5-C329-4816-B865-0D5426F4F7E6Q57028962-25B0BE96-FCC9-46E4-9B8B-97128AC434B6Q57235317-729BA87D-2684-494B-8CC7-8FC8616B80CAQ57250081-59B8A561-8DD2-45FD-8E59-592F4C203DC9Q58887521-93EAF4D3-02B3-4CF5-AC31-847FD531A0D0Q58890364-D84753E8-FDFA-4BE8-8FB4-2E7ECE71AC06Q59535156-61C8AF76-101E-48FB-90D3-6CD7418B9DDEQ59662279-208126C8-9D4A-41AD-949B-BA3E816B670BQ59677307-C526A22A-4F80-4939-963B-6254A6A8C164Q59685709-93F5956D-A255-4F52-A719-7805065891A7Q59689629-0FAA1A5D-744E-48EC-A72A-EEDAB98824C1Q59691359-2C64599F-BAE6-4F27-86B5-183E0B5E1225Q59695933-3E28BF47-3E5A-4A67-957A-FDAE29A6F268Q60673533-28421A28-3DB7-4BB7-B52C-B08498BD4CD5Q61313224-F490B866-2DCF-45A5-8A93-339837FF994AQ62755418-970A7F57-2310-40D0-B65F-16DD9E28C112Q62956377-BB4A9A1B-19A1-4F7F-B0B2-C1B46829F106Q63968643-8FD75767-72BA-4775-8D5E-D38E702A3A74Q64712784-70A24E3E-AD02-49C4-8754-DC6E621D1F1EQ64916427-BC2D48EB-6345-4745-AB4D-716A4E1E9B44Q70500545-C656521C-B640-4BAE-9C07-56C92EA26305Q73082190-3455754B-697C-4E91-9D49-1526E697DBB5
P108
Q58407554-715CBC78-99BB-4010-815A-2C60BC1BC62EQ58407717-2A0CA08E-F206-4E5C-B99B-9B2472E697D4Q58844832-EFF49ADC-C24E-4CD0-BFB5-90BB0DB43355Q58846367-EB3EFE3F-3A9E-4C00-949F-A9B668B3A04EQ61914677-D6349377-F615-4603-B3CF-50FF776BB0CDQ61915549-3BAF5F4A-827E-4C81-95E2-0076BEF7072FQ61917963-666EBC4C-087C-4506-AF8E-E773FDDE8088Q61920856-AA02B057-9A7D-400F-913D-01A13183B612Q61921134-85047987-AB6E-4358-A9FE-E3E3217E3CAEQ61921505-A705AF82-4C68-4FAC-9EAE-4D4230F2F3B7Q61921538-99581C8C-BEC0-48C5-A4B5-E4D2BCB51B4FQ61922040-F56407E9-EB76-43E3-8537-DA14895F243FQ61934419-FD1C5055-39B7-429C-B16D-EFD85C66B32EQ61936104-023A9136-FE28-4EB8-AADB-21D88166CB1FQ61965924-11C6DF7F-48C8-4A2F-B732-4F9263A60BE1Q61966725-C9AFB7B5-4637-40CA-BEF5-E0AD1F4B3B3CQ61979131-5CDAC7CC-AC76-4596-A30C-1075ADC95E6CQ61981025-9B975034-0CD0-4C50-8C9E-1C0740E4ABCFQ61981182-EF5F785D-C89E-46DC-80F0-0CC68293FA5CQ62035088-BE6F8B86-5D8A-485F-AE84-9F6A203B3FBAQ62062216-352787BD-B562-4B42-8427-6EF5FE3E16F3Q62062216-7D4BEC73-565C-4467-881C-FD88B5161BCCQ62104853-C850F9DE-ECC6-4AFD-8042-1F3FF043303AQ62105276-8B064242-D815-4CDD-B150-29FADC356E7FQ62105336-CD81CB21-CCA6-4121-A856-C7F7CF8196DFQ62105688-FD992C0C-6E39-4E0A-AED2-4F42900A38D2Q62105716-7F67A25E-1DD3-457B-9D28-845929470AF3Q62105745-3B13FC07-9753-4B14-A057-9C0593942ACFQ62105945-63A55ADB-A7CE-4FEC-A438-012F70AED489Q62105958-437C7AF6-D217-4407-BC93-3C2B6816F42CQ62812435-EA65D83B-745F-416E-AA91-40B7EE25786DQ63012949-5655A775-560B-4759-B564-34321142BB59Q63316928-D2D5055F-A59E-4060-A4EB-7CEA44536658Q63319356-B7D505EB-8510-42D9-A04C-98EA7341F56EQ63322169-A27B3B91-FFB7-432A-BBAE-014FDC4A9537Q63334521-D7CF14C7-D705-4228-B5A6-18EBA75E1744Q63340220-3BB69E29-D7D3-45D6-A407-62C79BF17A7EQ63394394-128A290B-CD20-430E-81FE-1474BFBA6F2FQ63571337-0179ABDF-4919-40E7-96A0-4C25436A7D5DQ63571898-1A254407-23DD-4E00-B5BC-085E559E61F9
P6153
description
Krankenhaus
@de
americká firma
@cs
griya sakit
@jv
hospital d'Estaos Xuníos
@ast
hospital
@en
hôpital
@fr
rumah sakik
@min
rumah sakit di Amerika Serikat
@id
rumoh sakét
@ace
ziekenhuis in Californië, Verenigde Staten van Amerika
@nl
name
?年
@ja
City of Hope National Medical Center
@en
City of Hope National Medical Center
@fr
希望之城國家醫學中心
@zh
type
label
?年
@ja
City of Hope National Medical Center
@en
City of Hope National Medical Center
@fr
希望之城國家醫學中心
@zh
altLabel
City of Hope
@en
希望之城國家醫療中心
@zh
prefLabel
?年
@ja
City of Hope National Medical Center
@en
City of Hope National Medical Center
@fr
希望之城國家醫學中心
@zh
P1278
P1566
P214
P244
P3153
P3347
P6366
P1278
5493006FAVIK5LI8NV34
P1297
95-3435919
P1315
P1566
P159
P169
P2002
cityofhope
P2003
cityofhope